“Extending the life of transplanted kidneys would mean fewer patients going back on dialysis or needing a second transplant – relieving pressure on waiting lists that in the
The post Novartis presents first-of-its-kind histology data with iscalimab appeared first on Pharmaceutical Business review.
Original Article: Novartis presents first-of-its-kind histology data with iscalimab